![](/img/cover-not-exists.png)
INTERIM UPDATE FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA
Morschhauser, F., Tilly, H., Chaidos, A., Phillips, T., Ribrag, V., Campbell, P., Ghandi Laurent, D., Jurczak, W., McKay, P., Opat, S., Radford, J., Rajarethinam, A., Yang, J., Howell, H., Newberry, KVolume:
37
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.111_2629
Date:
June, 2019
File:
PDF, 244 KB
english, 2019